GILD vs NEU · P/E 18, rev $7.80B vs P/E 15, rev $1.42B
Gilead Sciences Inc (GILD) versus NewMarket Corporation (NEU) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
NewMarket Corporation (NEU) is a specialty chemicals company listed on US.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported NEU revenue for 2026-06-30 was $1.42B. Net income was $251.8M. NEU currently screens at market cap $6.96B and trailing P/E 14.7.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. NEU currently screens at market cap $6.96B and trailing P/E 14.7.
Not investment advice. Open the GILD and NEU stock pages for the full models.
Not investment advice.